Category Archives : News

Home  >>  News

Heidelberg University: QS subject rankings published

On March 22, 2016, Posted by , In News, With No Comments

Four humanities subjects at Heidelberg University are among the leading disciplines represented in the recently published QS World University Rankings by Subject. Archaeology ranks 23rd, modern languages 27th, philosophy 33rd and history 46th. “The principle of a comprehensive university that promotes interdisciplinary dialogue based on disciplinary strengths is a central…

Altered DNA methylation as a warning sign of radiation-induced fibrosis

On March 18, 2016, Posted by , In News, With No Comments

Radiation-induced fibrosis is a common late effect of radiation therapy. In a study on breast cancer, scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and Mannheim University Hospital have now identified an epigenetic pattern that indicates an increased risk of fibrosis. In the future, this epigenetic characteristic might…

FDA grants Roche’s Cancer Immunotherapy Atezolizumab priority review for advanced bladder cancer

On March 15, 2016, Posted by , In News, With No Comments

Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA) and granted Priority Review for atezolizumab (anti-PDL1; MPDL3280A) for the treatment of people with locally advanced or metastatic urothelial carcinoma (mUC) who had disease progression…

Merck Finishes Record Year 2015 Stronger

On March 8, 2016, Posted by , In News, With No Comments

Net sales (+13.0%) and EBITDA pre exceptionals (+7.1%) reach new record levels All three business sectors deliver organic growth Asia-Pacific region drives Group sales growth Merck meets targets for 2015 Proposed dividend to increase to € 1.05 (+5%) Darmstadt, Germany, March 8, 2015 – Merck, a leading science and technology…

Octapharma Group publishes 2015 annual results reporting revenue of €1.5 billion and operating income of €351 million

On March 8, 2016, Posted by , In News, With No Comments

Lachen, Switzerland, March 8th, 2016: the Octapharma Group publishes its 2015 annual results reporting revenue of 1.513 billion Euro, representing an increase of 233 million Euro or 18.2% compared with the 2014 figure. Gross profit in 2015 was 582 million Euro, 140 million Euro higher than in 2014. The reported…